Pregnancy outcomes in women with liver disease: Is pregnancy safe? A cross-sectional study


Background: There is evidence suggesting that the pregnancy outcome may be affected by some medical conditions, such as liver diseases.

Objective: The present study aimed to investigate the prevalence of liver disease and its outcomes in pregnant women referred to antenatal clinic in the hospital.

Materials and Methods: In this cross-sectional study, all pregnant women with abnormal liver function test attending antenatal clinic affiliated to Shahid Beheshti University of Medical Sciences were recruited from August 2017 to July 2018. All participants were followed-up until delivery with respect to the maternal and neonatal outcome.

Results: Of a total of 7,121 pregnant women recruited in the study, 110 (1.58%) women were detected with a liver disease; of these, 105 women were diagnosed with pregnancy-specific liver diseases, including HELLP syndrome (10.9%), preeclampsia (50.98%), partial HELLP (0.9%), eclampsia (0.9%), acute fatty liver (9.1%), intra-hepatic cholestasis 25 (22.7%), and 5 women the non-pregnancy-specific liver disease, including Liver transplantation (2.7%), and Autoimmune hepatitis (1.8%). Prevalence of the premature birth was 64.5% in pregnancy-specific liver disease, but no premature birth was detected in cases with liver transplantation. We found that neonatal mortality was significantly associated with neonatal prematurity (p = 0.013), IUGR (p < 0.001), placental pathology (p = 0.04), we had no maternal mortality.

Conclusion: Liver disease is not uncommon in pregnancy. This study demonstrated that pregnancy is safe in women with liver disease.

Key words: Liver diseases, Maternal, Outcome, Neonatal, Pregnancy.

[1] Pan C, Perumalswami PV. Pregnancy-related liver diseases. Clin Liver Dis 2011; 15: 199–208.

[2] Solanke D, Rathi C, Pandey V, Pati M, Phadke A, Sawant P. Etiology, clinical profile, and outcome of liver in pregnancy with predictors of maternal mortality: A prospective study from western india. Indian J Gastroenterol 2016; 35: 450– 458.

[3] Karegoudar D, Dhirubhai PR, Dhital M, Amgain K. A study of liver disorder and its consequences in pregnant women with jaundice in tertiary care centre in Belgaum, Karnataka, India. Journal of Dental and Medical Sciences 2014; 13: 14–18.

[4] Tiwari A, Aditya V, Srivastava R, Gupta G. A study of spectrum and outcome of liver diseases in pregnant women at BRD medical college. Int J Reprod Contracept Obstet Gynecol 2017; 6: 3641–3645.

[5] Esposti SD. Pregnancy in patients with advanced chronic liver disease. Clin Liver Dis 2014; 4: 62–68.

[6] Rezk M, Gamal A, Emara M. Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study. Hypertens Pregnancy 2015; 34: 137–144.

[7] Carballo-Nunez E, Gonzalez-Rodrlguez L, Gonzalez- Boubeta R, Maria Teresa AP. Perinatal outcomes in patients with cholestasis of pregnancy. Ginecol Obstet Mex 2015; 83: 776–784.

[8] Bacq Y, Sentilhes L. Intrahepatic cholestasis of pregnancy: Diagnosis and management. Clin Liver Dis 2014; 4: 58–61.

[9] Bouwers L, Koster MPH, Page-christiaens GCML, Kemperman H, Boon J, Evers IM, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015; 212: 100: e1–e7.

[10] Kurt A, Ecevit A, Kisa B, Anuk Ince D, Tarcan A, et al. Neonatal outcomes of pregnancy with intrahepatic cholestasis. Perinatal Journal 2011; 19: 10–14.

[11] Lin J, Gu W, Hou Y. Diagnosis and prognosis of early-onset intrahepatic cholestasis of pregnancy: a prospective study. J Matern Fetal Neonatal Med 2019; 32: 997–1003.

[12] Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, Bull L. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One 2012; 7: e28343: 1–6.

[13] Sharma P, Sarkar B, Majhi B. Fetal and neonatal outcomes in intrahepatic cholestasis of pregnancy. Int J Reprod Contracept Obstet Gynecol 2018; 7: 4056–4060.

[14] Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12- year population-based cohort study. BJOG 2013; 120: 717– 723.

[15] Holub K, Camune B. Caring for the woman with acute fatty liver of pregnancy. J Perinat Neonatal Nurs 2015; 29: 32– 40.

[16] Orgul G, Ozcan EU, Celik HT, Beksac MS. Autoimmune hepatitis and pregnancy: report of two cases with different maternal outcomes. Clin Exp Hepatol 2017; 3: 212–214.

[17] Costa MLB, Surita FGC, Passini Jr R, Cecatti JG, Boin IFS. Pregnancy outcome in female liver transplant recipients. Transplant Proc 2011; 43: 1337–1339.

[18] Parhar KS, Gibson PS, Coffin CS. Pregnancy following liver transplantation: Review of outcomes and recommendations for management. Can J Gastroenterol 2012; 26: 621–626.

[19] Lindenmeyer CC, Mccullough AJ. Pregnancy outcomes and reproductive health after liver transplantation. Clin Liver Dis 2016; 6: 142–144.

[20] Krishnamoorthy J, Murugesan A. Jaundice during pregnancy: maternal and fetal outcome. Int J Reprod Contracept Obstet Gynecol 2016; 5: 2541–2545.